Clinical trial
Safety and Efficacy of the Drug Eluting Balloon (DEB) for the Treatment of the Superficial Femoral Artery (SFA) Ischemic Vascular Disease in Symptomatic Patients Presenting With Long Lesions: a Pilot Study
NCT01658540 is registered in ClinicalTrials.gov with Ettore Sansavini Health Science Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of the Drug Eluting Balloon (DEB) for the Treatment of the Superficial Femoral Artery (SFA) Ischemic Vascular Disease in Symptomatic Patients Presenting With Long Lesions: a Pilot Study
- Lead sponsor
- Ettore Sansavini Health Science Foundation
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- May 31, 2016
- Enrollment
- 105 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral artery disease